Scholarly Index
Sarat Chandarlapaty
Memorial Sloan Kettering Cancer Center; 25,512 total citations; 383 total publications; best world rank #23
Memorial Sloan Kettering Cancer Center
25,512Total citations
383Total publications
73H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| HER2/EGFR in Cancer Research | Lifetime | 205 | US 103 | 99.07 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 144 | US 85 | 98.67 |
| Advanced Breast Cancer Therapies | Lifetime | 136 | US 66 | 98.78 |
| Cancer Treatment and Pharmacology | Lifetime | 962 | US 456 | 97.45 |
| HER2/EGFR in Cancer Research | 2021-2025 | 60 | US 23 | 99.02 |
| Advanced Breast Cancer Therapies | 2021-2025 | 57 | US 24 | 98.98 |
| Estrogen and related hormone effects | 2021-2025 | 30 | US 17 | 96.74 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 23 | US 16 | 95.61 |
| Cancer Treatment and Pharmacology | 2021-2025 | 89 | US 30 | 98.28 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 241 | US 87 | 95.70 |
| Cancer-related Molecular Pathways | 2021-2025 | 240 | US 99 | 88.90 |
| Breast Cancer Treatment Studies | 2021-2025 | 894 | US 310 | 90.82 |